Study Stopped
Unanticipated technical issues and COVID-19 related-disruptions precluded enrollment of participants before the end of the award period.
M-Health for Teen Substance Abuse and Mental Illness Pilot
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The study is exploring the ease and ability to integrate a mobile application in outpatient behavioral health treatment. There are two major aims to the study: 1) Determine feasibility and acceptability of integrating a mobile app into behavioral health treatment for adolescents with co-occurring substance use and mental health disorders, and 2) identify initial signal of effect on engagement and/or treatment outcomes among youth who use the mobile app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2020
CompletedFirst Posted
Study publicly available on registry
February 24, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedApril 6, 2022
March 1, 2022
1 year
January 31, 2020
March 28, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Percent of patients retained in study protocol
Retention of \>75% of adolescents through assessments measured by study participant enrollment records. The retention rate will be measured by the number of sessions attended.
4 months post-baseline
Provider satisfaction assessed by Treatment Evaluation Inventory-Short Form (TEI-SF)
Providers express high satisfaction with e-tools per published norms on the TEI-SF. The Treatment Evaluation Inventory Short Form (TEI-SF) is a 9-item questionnaire that is rated on a 5-point scale. Scores range from 9 to 45 for each treatment with higher scores indicating greater acceptability of the model.
4 months post-baseline
Adolescent satisfaction assessed by the Client Satisfaction Questionnaire (CSQ)
Adolescents express high satisfaction with e-tools per published norms. The Client Satisfaction Questionnaire-8, an 8 question survey with ratings from 1 to 4 is used. Scores can range from 8 to 32 with higher scores indicating greater satisfaction.
4 months post-baseline
Patient Engagement assessed by the Child Improvement Rating Scale (CIRS)
Provider-rated youth engagement in treatment process.This will be assessed by the Child Involvement Rating Scale (CIRS) which is a 6 item questionnaire with each item being rated on a 6 item scale ranging from 0 to 5. The questionnaire contains 4 items assessing positive involvement and 2 items assessing negative involvement. The positive items are scored according to the selected scale value while the negative involvement items are reverse scored. Higher scores correspond to greater perceived patient involvement.
4 months post-baseline
Secondary Outcomes (4)
Substance Use Disorder (SUD) Symptoms measured by CRAFFT
4 months post-baseline
Substance Use Disorder (SUD) Symptoms assessed by the Drug Abuse Screening Test for Adolescents (DAST-20-A)
4 months post-baseline
Post-Traumatic Stress Disorder (PTSD) Symptoms (If applicable)
4 months post-baseline
Therapeutic alliance as measured by the Therapeutic Alliance Scale for Children-Revised (TASC-R)
4 months post-baseline
Study Arms (1)
Mobile App
EXPERIMENTALYouth will be assigned to interact with a novel mobile application during a course of outpatient psychotherapy for substance use disorder(s) and co-occurring mental health disorder(s).
Interventions
The Bright Path web-based mobile application is designed to target co-occurring problems, enhance patient treatment engagement, and contribute to lasting improvements in teens' mental health. The central hypothesis is that developmentally tailored mobile applications that incorporate evidence-based treatment principles can facilitate increased patient engagement in and between sessions, thus, improving the efficiency, efficacy, and reach of treatments for this highly vulnerable population.
Eligibility Criteria
You may qualify if:
- Aged 14-17 years
- Current substance use disorder (SUD)
- Co-occurring mental health disorder
- Treatment-seeking
- English-speaking (Only English documents will be used throughout the course of this research study)
You may not qualify if:
- Younger than 14 or older than 17
- Endorsement of active suicidal or homicidal ideation
- Active mania or psychosis
- Significant cognitive disability, developmental delays, or pervasive developmental disability
- No history of outpatient psychotherapy.
- Clinician delivering outpatient dual diagnosis treatment (i.e., for co-occurring SUDs and mental health disorders)
- Therapist with at least a Master's degree in a counseling related field
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zachary W Adams, PhD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 31, 2020
First Posted
February 24, 2020
Study Start
August 1, 2020
Primary Completion
August 1, 2021
Study Completion
August 1, 2021
Last Updated
April 6, 2022
Record last verified: 2022-03